Projects funded by the NCN

Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

Call: SONATA 17 , Panel: NZ7

Principal investigator: dr Monika Anna Musiał-Kulik

Centrum Materiałów Polimerowych i Węglowych PAN

In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Anna Karolina Pogorzelska

Narodowy Instytut Leków

Drug repurposing to target p53 protein family for improved therapy in the relapsed TP53 and EGFR mutated lung cancer

Call: OPUS 20 , Panel: NZ7

Principal investigator: dr Joanna Elżbieta Zawacka-Pankau

Warszawski Uniwersytet Medyczny

A novel approach based on the optimized multidrug combination for glioblastoma treatment.

Call: SONATA 16 , Panel: NZ7

Principal investigator: prof. Małgorzata Kucińska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Combination of Molecular Simulation and Deep Learning for De Novo Drug Design

Call: PRELUDIUM 19 , Panel: ST6

Principal investigator: dr Tomasz Jakub Danel

Uniwersytet Jagielloński, Wydział Matematyki i Informatyki

Study on metabolism of microorganisms treated with metal nanoparticles, antibiotics, metal ions and their combinations u...

Call: PRELUDIUM 13 , Panel: ST4

Principal investigator: Agnieszka Maria Rogowska

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Old drugs - new perspectives: modulation of antibiotics activity by caffeine and pentoxifylline

Call: SONATA 11 , Panel: NZ7

Principal investigator: dr Anna Woziwodzka

Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

Evaluation of novel, synergistic drug combinations for the treatment of B cell malignancies

Call: OPUS 11 , Panel: NZ7

Principal investigator: dr Małgorzata Firczuk

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate releas...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Joanna Monika Wierońska

Instytut Farmakologii PAN

Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

Assessment of virulence, biofilm formation and drug-susceptibility of Candida albicans treated with plant essential oils...

Call: PRELUDIUM 1 , Panel: NZ6

Principal investigator: Aleksandra Budzyńska

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska